|
Featured SoCalBio Member
Keck
Craig is a Pasadena-Calif.-based
firm providing product
engineering, machine development
& industrial design services
that utilize ergonomics,
appearance, safety, performance
& production considerations
for medical, industrial &
consumer applications. Learn
more
|
|
SoCalBio
Resources
|
| Looking
for professionals
offering regulatory, QC,
pre-clinical and clinical services? |
| Use SoCalBio-affiliated
firms. Click here to see
listing |
|
Vivarium Amenities
Available
|
|

|
|
A Santa Clarita-based biotech
company has a state-of-the-art Vivarium that
is not fully utilized. If you
would like to access this facility
to conduct research at reasonable
rates, please contact SoCalBio at
213-236-4890 for more
information.
|
|
Executive Global
Business Series: Doing Business
In China
|
|

|
|
Jan 26-28,
2009
Rady Center for Executive Development, UC San Diego
San Diego, CA
Click for more
info
In partnership
with the School of International
Relations and Pacific Studies, learn
strategies for sourcing, designing
and marketing products, and
investing in China.
Experience a
full traditional Chinese dinner
including etiquette and protocol.
This course will teach you
everything you need to know about
doing business in China.
Regular
Program Fee: $2,150. Early Bird
Discount $1,950* (discount ends Dec
31)
|
Become a Member
Join well-known entrepreneur
Alfred Mann and other SoCalBio leaders to
promote the biotech and device
industries in the Greater Los
Angeles Metro Area for job
creation and overall economic
growth.
|
|

|
|
|
| RSVP
Now |
SoCalBio
Networking Forum
November 20, 2008
4:00 pm - 7:00 pm
UCLA Faculty Club
Event
Focus
Can
Medtech and Biotech Weather the
Current Economic Turmoil?
Keynote
Speaker
John
L. Babitt, Transaction
Advisory Services,
Ernst & Young LLP
Mr. Babitt
co-authored a new study arguing
that, notwithstanding the
worldwide credit slowdown that has
stalled public-equity
financing, the medtech
industry's fundamentals are strong
and key drivers, such as the aging
populations, the spread of chronic
conditions and an expected surge
in demand for companion
diagnostics for use with new
generations of targeted
therapeutics, will fuel
industry's growth in the coming
years. Join us to participate
in a discussion about the future
of the medtech industry as a job
growth driver throughout the U.S.,
in general, and in the Greater Los
Angeles region, in particular.
|
| Device
Talk |
- The
Device Industry Flourishes in
America's Heartland and Out West
MPMN
takes a look at the medtech
industry's presence in hotbeds
such as Minnesota and California (see SoCalBio
directory of bioscience firms in the
six counties of greater Los Angeles),
as well in several up-and-coming
hubs located in Missouri, Michigan,
Ohio, and South Dakota ... Read article
In the Inland Empire, medical
device manufacturers can gain easy
access to a multitude of suppliers
and service providers. The region
(see SoCalBio
directory of bioscience firms in
the Inland Empire) lends
itself to facility expansion,
inspires exploration, and
encourages industry growth ... Read more
The U.S. market for
reconstructive joint replacements
and spinal hardware is valued at
$17.3 billion. As it grows,
the market seems to be getting
more personal, with an increase in
the use of patient-specific
implants. New technology is
enabling quick, cost-effective
creation of exactly the right hip,
knee, shoulder, or spinal section
for an individual patient in a
matter of weeks, not months .... Read more
|
| The
Biosciences and the Capital Freeze |
-
In
Capital Freeze, Some Life-Sci
Startups Look for Warmth
from SBIR, STTR Grants
The ongoing financial meltdown
is drying up traditional sources
of financing for early-stage
life-science companies, leading
them to pursue alternatives,
such as SBIR and STTR grants (see upcoming
SoCalBio workshop), they may not
ave otherwise considered ... Read article
- Biotechs
Claw for Their Lifeblood -
Financing
Although the biotech field in
general is a sheltered habitat
compared with the harsh business
landscape in other sectors, many
smaller biotech companies are
struggling to survive. Infusions
of cash, the essential
nourishment that allows
fledgling biotechs to grow for
years until they finally market
a product, have been cut off as
banks, hedge funds and other
sources mete out their
investments to lower-risk
businesses ...Read more
Biotech companies have been
seen as a safe haven in tough
economic times, with stable
earnings that are not dependent
upon other economic factors. The
companies are proving to be far
removed from the broader market
and the turmoil on Wall Street ... Read more
|
| The
Biotech Effect |
In a study of 974 cancer
drugs, the Cancer Research
UK found that, if current
trends continue, about 18 percent
of those would make it
through clinical
development to become
standard treatments; that's up
from previous estimates of 5
percent. Not only are
more drugs making it to
market, but these
modern drugs have fewer
side effects than the
traditional cancer drugs ... Read more
|
| Big
Pharma Continues to Shed off Jobs |
Companies like Pfizer, AstraZeneca
and Bayer posted the
biggest layoff numbers in
2007. In 2008 patent expirations,
drug safety problems and a general
need to become leaner and meaner
put Merck, Schering-Plough, Wyeth,
UCB and Abbott at the top of this
list ... Click here to see
the numbers
|
| Government |
- Democratic
Lawmakers Call for Spiking NIH
Funding in Economic Stimulus
Bill
Senate Majority Leader Harry
Reid (D-Nev.) introduced an
economic stimulus bill that
includes an additional $1 billion
in funding for the National
Institutes of Health for fiscal
2008... Read more
- Allegations
of Corruption Could Leave FDA in
Turmoil
Top managers with the U.S. Food
and Drug Administration
``corrupted and interfered
with'' scientific reviews of
medical devices, agency
scientists said in
a letter that is
sparking a congressional
investigation ... Read more
|
|
Local Company Headlines
|
|
FDA Panel Wants
More Warnings On Wrinkle Fillers
Edwards
Lifesciences (Irvine):
Endologix
(Irvine):
IDM
Pharma (Irvine):
ISTA
Pharmaceuticals (Irvine):
Valeant
Pharmaceuticals (Aliso Viejo):
Watson
Pharmaceuticals (Corona):
|
| Jobs
Available |
- NeuroSystec (www.neurosystec.com)
Valencia, CA
- Director of Engineering-
Regular, Full-Time
- Manager, Analytical
Development - Regular,
Full-Time
- Bioness (www.bioness.com)
Valencia, CA
- Inside Sales - Customer
Service - Regular, Full-Time
(3 openings)
- Customer Service Manager -
Regular, Full-Time
- Business Development
Representative -
Regular, Full-Time
- Clinical Specialists-
Regular, Full-Time
- Numerous positions across
the United States and Canada
for Physical or Occupational
Therapists
- Physical or Occupational
Therapist for Valencia, CA
headquarters
- Second
Sight (www.2-sight.com)
Sylmar, CA
- Sr. Software Engineer -
Regular, Full-Time
- DermaPort (www.dermaport.com)
Valencia, CA
- Principal Design Engineer
- Regular, Full-Time
- Implanted
Acoustics (www.implantedacoustics.com)
Valencia, CA
- Principal Mechanical
Design Engineer - Regular,
Full-Time
Click here to see
details and submit resume
|
| Do
you know? |
|
SoCalBio membership
provides access to significant
discounts on purchases of industrial
and medical grdae-gas from Linde through
the SoCalBio Group Purchasing
Program designed for small and
mid-size firms. Through
the partnership with Linde, which
is among the world's largest
industrial gases organizations,
SoCalBio members are offered
the following benefits:
- Competitive, preferred,
negotiated pricing on Linde's
complete suite of gas products
and gas application and related
equipment, products, and
services
- Annual cash rebate, based on
the aggregate purchase volume of
all participating member
companies
- 10% discount off standard
rental for bulk storage tanks
- Service provided by Linde's
distributors as assigned by
Linde to each market
- Additional rebate available
for referrals
For more information,
call 213-236-4890 or send
e-mail to scbc@socalbio.org
|
| About
SoCalBio |
 SoCalBio membership
links you to partners, contract
manufacturers, regulatory and
legal experts, and policy makers.
The organization's programs help
emerging biotech and medical
device companies grow. Membership
is affordable -- as low as $500 --
and offers access to networking
opportunities, advocacy, discounts
through our group purchasing
program group purchasing
program and
other benefits you simply can't find
elsewhere ... Join SoCalBio
|
| Editor: Ahmed A. Enany
Southern California Biomedical
Council (SoCalBio)
|
|
|